HRT Financial’s Trillium Therapeutics Inc. TRIL Stock Holding History

HRT Financial’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-113,999	Closed	-$2M	–	4498
2021 Q3	$2M	Buy	+113,999	New	+$1.33M	0.01%	737

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

HRT Financial's TRIL Position: Q4 2021 in Review

HRT Financial sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 113,999 shares — an estimated $2M sold.

HRT Financial first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $2M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

HRT Financial reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
HRT Financial sold 113,999 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $2M.
HRT Financial first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
HRT Financial's Trillium Therapeutics Inc. position peaked at $2M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on HRT Financial's 13F filing for Q4 2021, filed 14 Feb 2022.